Multi-agent chemotherapy overcomes glucocorticoid resistance conferred by a BIM deletion polymorphism in pediatric acute lymphoblastic leukemia
10.1371/journal.pone.0103435
Saved in:
Main Authors: | Soh S.X., Lim J.Y.S., Huang J.W.J., Jiang N., Yeoh A.E.J., Ong S.T. |
---|---|
Other Authors: | PAEDIATRICS |
Format: | Article |
Published: |
Public Library of Science
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/142472 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Overcoming imatinib resistance conferred by the BIM deletion polymorphism in chronic myeloid leukemia with splice-switching antisense oligonucleotides
by: Liu, J, et al.
Published: (2020) -
Overcoming imatinib resistance conferred by the BIM deletion polymorphism in chronic myeloid leukemia with splice-switching antisense oligonucleotides
by: Liu, Jun, et al.
Published: (2018) -
BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia
by: Jiang, N., et al.
Published: (2014) -
The HDAC inhibitor SB939 overcomes resistance to BCR-ABL kinase Inhibitors conferred by the BIM deletion polymorphism in chronic myeloid leukemia
by: Rauzan M., et al.
Published: (2020) -
Monitoring of cytomegalovirus infection in non-transplant pediatric acute lymphoblastic leukemia patients during chemotherapy
by: Nonthapan Phasuk, et al.
Published: (2020)